Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Cristina Caroleo

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Special Issue "GPCRs: Ligands and beyond 2022"Erika Cione, Maria Cristina Caroleo
Journal of Enzyme Inhibition and Medicinal Chemistry|February 2, 2021
Pharmacophore-guided repurposing of fibrates and retinoids as GPR40 allosteric ligands with activity on insulin releaseErika Cione, Maria Cristina Caroleo, Hiroyuki Kagechika, et al.
Alcohol (Fayetteville, N.Y.)|May 21, 2005
Nerve growth factor produced by activated human monocytes/macrophages is severely affected by ethanolMaria Cristina Caroleo, Nicola Costa, Paola Tirassa, et al.
European Journal of Medicinal Chemistry|August 12, 2017
From the hive: Honey, a novel weapon against cancerMariateresa Badolato, Gabriele Carullo, Erika Cione, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Exosome microRNAs in Metabolic Syndrome as Tools for the Early Monitoring of Diabetes and Possible Therapeutic OptionsErika Cione, Roberto Cannataro, Luca Gallelli, et al.
Antioxidants (Basel, Switzerland)|March 6, 2021
Polyphenols in the Mediterranean Diet: From Dietary Sources to microRNA ModulationRoberto Cannataro, Alessia Fazio, Chiara La Torre, et al.
Colloids and Surfaces. B, Biointerfaces|October 31, 2012
Doxorubicin loaded magneto-niosomes for targeted drug deliveryLorena Tavano, Marco Vivacqua, Valentina Carito, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Discovery of 1,4-Naphthoquinones as a New Class of Antiproliferative Agents Targeting GPR55Mariateresa Badolato, Gabriele Carullo, Maria Cristina Caroleo, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2019
Quercetin-3-oleoyl derivatives as new GPR40 agonists: Molecular docking studies and functional evaluationGabriele Carullo, Mariarita Perri, Fabrizio Manetti, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2021
FFAR1/GPR40: One target, different binding sites, many agonists, no drugs, but a continuous and unprofitable tug-of-war between ligand lipophilicity, activity, and toxicityPaolo Governa, Maria Cristina Caroleo, Gabriele Carullo, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Special Issue "GPCRs: Ligands and beyond 2022"Erika Cione, Maria Cristina Caroleo
Journal of Enzyme Inhibition and Medicinal Chemistry|February 2, 2021
Pharmacophore-guided repurposing of fibrates and retinoids as GPR40 allosteric ligands with activity on insulin releaseErika Cione, Maria Cristina Caroleo, Hiroyuki Kagechika, et al.
Alcohol (Fayetteville, N.Y.)|May 21, 2005
Nerve growth factor produced by activated human monocytes/macrophages is severely affected by ethanolMaria Cristina Caroleo, Nicola Costa, Paola Tirassa, et al.
European Journal of Medicinal Chemistry|August 12, 2017
From the hive: Honey, a novel weapon against cancerMariateresa Badolato, Gabriele Carullo, Erika Cione, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Exosome microRNAs in Metabolic Syndrome as Tools for the Early Monitoring of Diabetes and Possible Therapeutic OptionsErika Cione, Roberto Cannataro, Luca Gallelli, et al.
Antioxidants (Basel, Switzerland)|March 6, 2021
Polyphenols in the Mediterranean Diet: From Dietary Sources to microRNA ModulationRoberto Cannataro, Alessia Fazio, Chiara La Torre, et al.
Colloids and Surfaces. B, Biointerfaces|October 31, 2012
Doxorubicin loaded magneto-niosomes for targeted drug deliveryLorena Tavano, Marco Vivacqua, Valentina Carito, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Discovery of 1,4-Naphthoquinones as a New Class of Antiproliferative Agents Targeting GPR55Mariateresa Badolato, Gabriele Carullo, Maria Cristina Caroleo, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2019
Quercetin-3-oleoyl derivatives as new GPR40 agonists: Molecular docking studies and functional evaluationGabriele Carullo, Mariarita Perri, Fabrizio Manetti, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2021
FFAR1/GPR40: One target, different binding sites, many agonists, no drugs, but a continuous and unprofitable tug-of-war between ligand lipophilicity, activity, and toxicityPaolo Governa, Maria Cristina Caroleo, Gabriele Carullo, et al.
Pageof 7